Anaplastic large-cell lymphoma with atypical chromosomal translocation t(2;5) and hypophyseal tumor

Yazar: Wang, Lei, Tong, Yin, Chen, Zhimei, Xu, Weilai, Jin, Jie
Baskı/Yayın Bilgisi 2010

Downregulation of hTERT: An Important As(2)O(3) Induced Mechanism of Apoptosis in Myelodysplastic Syndrome

Yazar: Xu, Weilai, Wang, Yungui, Tong, Hongyan, Qian, Wenbin, Jin, Jie
Yayımlandı PLoS One (2014)

Efficacy and safety of homoharringtonine plus cytarabine and aclarubicin for patients with myelodysplastic syndrome-RAEB

Yazar: XIAO, FENG, LI, YING, XU, WEILAI, YOU, LIANGSHUN, YANG, CHUNMEI, LIU, HUI, QIAN, WENBIN
Yayımlandı Oncol Lett (2016)

Acute myocardial/cerebral infarction as first/relapse manifestation in one acute promyelocytic leukemia patient

Yazar: Li, Ying, Suo, Shanshan, Mao, Liping, Wang, Lei, Yang, Chunmei, Xu, Weilai, Lou, Yinjun, Mai, Wenyuan
Yayımlandı Int J Clin Exp Med (2015)

Lower-dose decitabine improves clinical response compared with best supportive care in lower-risk MDS patients: a prospective, multicenter phase 2 study

Yazar: Ye, Li, Mei, Chen, Ren, Yanling, Zhou, Xinping, Ma, Liya, Xu, Weilai, Wei, Juying, Jiang, Huifang, Zhang, Liming, Zeng, Hui, Tong, Hongyan
Yayımlandı J Cancer (2021)

Real‐world data of chronic myelomonocytic leukemia: A chinese single‐center retrospective study

Yazar: Ma, Liya, Jiang, Lingxu, Yang, Wenli, Luo, Yingwan, Mei, Chen, Zhou, Xinping, Xu, Gaixiang, Xu, Weilai, Ye, Li, Ren, Yanlin, Lu, Chenxi, Lin, Peipei, Jin, Jie, Tong, Hongyan
Yayımlandı Cancer Med (2021)

Mutation status and burden can improve prognostic prediction of patients with lower‐risk myelodysplastic syndromes

Yazar: Jiang, Lingxu, Luo, Yingwan, Zhu, Shuanghong, Wang, Lu, Ma, Liya, Zhang, Hua, Shen, Chuying, Yang, Wenli, Ren, Yanling, Zhou, Xinping, Mei, Chen, Ye, Li, Xu, Weilai, Yang, Haiyang, Lu, Chenxi, Jin, Jie, Tong, Hongyan
Yayımlandı Cancer Sci (2019)

Clinical significance of cytogenetic and molecular genetic abnormalities in 634 Chinese patients with myelodysplastic syndromes

Yazar: Yan, Xuefen, Wang, Lu, Jiang, Lingxu, Luo, Yingwan, Lin, Peipei, Yang, Wenli, Ren, Yanling, Ma, Liya, Zhou, Xinping, Mei, Chen, Ye, Li, Xu, Gaixiang, Xu, Weilai, Yang, Haiyang, Lu, Chenxi, Jin, Jie, Tong, Hongyan
Yayımlandı Cancer Med (2021)

Impact of mutational variant allele frequency on prognosis in myelodysplastic syndromes

Yazar: Jiang, Lingxu, Wang, Lu, Shen, Chuying, Zhu, Shuanghong, Lang, Wei, Luo, Yingwan, Zhang, Hua, Yang, Wenli, Han, Yueyuan, Ma, Liya, Ren, Yanling, Zhou, Xinping, Mei, Chen, Ye, Li, Xu, Weilai, Yang, Haiyang, Lu, Chenxi, Jin, Jie, Tong, Hongyan
Yayımlandı Am J Cancer Res (2020)

Decitabine priming prior to low-dose chemotherapy improves patient outcomes in myelodysplastic syndromes-RAEB: a retrospective analysis vs. chemotherapy alone

Yazar: Ye, Li, Ren, Yanling, Zhou, Xinping, Mei, Chen, Ma, Liya, Ye, Xingnong, Wei, Juying, Xu, Weilai, Meng, Haitao, Qian, Wenbin, Mai, Wenyuan, Lou, Yinjun, Xu, Gaixiang, Qian, Jiejing, Lou, Yejiang, Luo, Yingwan, Xie, Lili, Lin, Peipei, Hu, Chao, Jin, Jie, Tong, Hongyan
Yayımlandı J Cancer Res Clin Oncol (2017)

The high NRF2 expression confers chemotherapy resistance partly through up-regulated DUSP1 in myelodysplastic syndromes

Yazar: Lin, Peipei, Ren, Yanling, Yan, Xiaomei, Luo, Yingwan, Zhang, Hua, Kesarwani, Meenu, Bu, Jiachen, Zhan, Di, Zhou, Yile, Tang, Yuting, Zhu, Shuanghong, Xu, Weilai, Zhou, Xinping, Mei, Chen, Ma, Liya, Ye, Li, Hu, Chao, Azam, Mohammad, Ding, Wei, Jin, Jie, Huang, Gang, Tong, Hongyan
Yayımlandı Haematologica (2019)